# Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder

> **NCT03558919** · PHASE4 · COMPLETED · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 81 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Mirabegron 25mg
- **DRUG:** Solifenacin Succinate 5 MG

## Key facts

- **NCT ID:** NCT03558919
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2017-12-30
- **Final completion:** 2017-12-30
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03558919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03558919, "Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03558919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*